At a glance
CDC works with partners in Central America to build sustainable public health capacity, strengthen laboratory systems and surveillance networks, deliver high-quality HIV and TB diagnostic, treatment, and prevention services, and respond swiftly to disease outbreaks at their source, preventing health threats from reaching the U.S.
Strategic focus
Since 2003, the U.S. Centers for Disease Control and Prevention (CDC) has collaborated with Ministries of Health (MOHs) to respond to the HIV epidemic in the region. CDC supports countries in Central America in achieving the UNAIDS 95-95-95 HIV testing, treatment, and viral load suppression targets.
In partnership with local governments, civil society, and other partners, CDC prioritizes interventions that directly impact the quality of services for people living with HIV (PLHIV) and people at greater risk for HIV. CDC supports the scale-up of evidence-based programs to close gaps in HIV prevention, active case finding, early antiretroviral therapy (ART) initiation, optimized treatment services, and viral load suppression. CDC uses a targeted approach to strengthen systems essential for a sustainable HIV response.
Read more about CDC's most recent key activities and accomplishments below.
Building public health capacity
- Introduced the Extension for Community Healthcare Outcomes (ECHO) model, an innovative tele-mentoring initiative where expert teams lead virtual clinics, amplifying the capacity for providers to deliver best-in-practice care to underserved communities. Through Project ECHO, CDC has created virtual communities of practice in HIV treatment, prevention, and strategic information.
- Launched the Continuous Quality Improvement Training Initiative, where participants learned how to apply concepts of quality improvement in the clinical setting to improve service quality.
- Established the HIV Rapid Test Continuous Quality Improvement Initiative.
- Supported MOHs in HIV surveillance to enhance data collection and analysis capabilities for improved decision-making.
- Worked closely with MOHs to build local capacity to perform regular evaluations and ensure high-quality standards in the viral load process.
- Provided expertise to MOHs to update HIV service manuals, adapt communication materials and job aids to the South American context, train health care workers in HIV combination prevention and viral load monitoring, and support integration of mobile populations with HIV into national health services.
Strengthening laboratory systems and networks
- Improved access to HIV testing among undiagnosed PLHIV by supporting active case-finding plans in CDC-supported health facilities. These include testing as part of outreach strategies for people at greater risk for HIV, index testing services, social network testing, optimized provider-initiated testing, self-testing, and testing among mobile populations.
- Implemented recent HIV infection surveillance to identify areas of active transmission (i.e., PLHIV infected in the past 12 months) to guide case finding and prevention strategies.
- Supported the HIV National Reference Laboratory in Honduras to get viral load accreditation by the International Organization for Standardization (ISO) 15189 for medical laboratories.
- Supported specimen referral, supplies, information, quality management systems, technology, and coverage of viral load services focused on increasing viral load coverage and suppression among PLHIV who receive clinical care in supported health facilities.
HIV prevention and treatment
- Expanded surveillance, prevention, and control strategy, known as VICITS. VICITS provides a tailored HIV prevention and testing service package. This package includes risk-based counseling HIV testing, peer navigation for linkage to treatment, and a surveillance information system.
- Contributed to the scale-up of pre-exposure prophylaxis (PrEP) as part of the VICITS package, including the introduction of on-demand PrEP.
- Supported provision of a comprehensive treatment package to connect newly diagnosed people with HIV to ART clinics for quick treatment, disease management, adherence counseling, and follow-up.
- Promoted optimized treatment regimens and the introduction of differentiated service delivery models, such as pharmacy fast-track refills, multi-month prescriptions, and high viral load tracking and management.
- Increased antiretroviral therapy access in hard-to-reach geographic areas.
- Supported a tailored HIV prevention and testing service package for mobile populations in Colombia and Peru. This package includes risk-based counseling, HIV testing, and peer navigation for linkage to treatment.
- Contributed to the introduction of PrEP for individuals at higher risk of HIV infection, including the TelePrep telemedicine model.
- Strengthened the direct service provision of a comprehensive treatment package for mobile populations that includes rapid ART initiation, diagnosis, and management of HIV advanced disease opportunistic infections. This includes tuberculosis, intensified adherence counseling, and follow-up of HIV patients.
- Sustained access to viral load testing among mobile PLHIV, as well as retention and re-engagement of those who are not in care or virally suppressed.
Tuberculosis prevention and treatment
- Promoted active referrals for TB treatment and managing other chronic conditions.
By the numbers
Colombia | El Salvador | Guatemala | Honduras | Nicaragua | Panama | Peru | |
---|---|---|---|---|---|---|---|
Global HIV Epidemic (2023) | |||||||
Estimated HIV Prevalence (Age 15–49) | 0.6% | 0.5% | 0.2% | 0.2% | 0.3% | 1.0% | 0.5% |
Estimated HIV Deaths (Age ≥15) | 3,500 | <500 | <500 | <500 | <200 | <500 | <1,000 |
Reported Number of Adults Receiving ART (Age ≥15) | N/A | 15,533 | 24,690 | 13,116 | 6,859 | 20,026 | 90,030 |
Global Tuberculosis Epidemic | |||||||
Estimated TB Incidence (Per 100,000 Population) (2023) | 46 | 84 | 33 | 31 | 43 | 58 | 173 |
Reported Percent of People with TB and HIV (2023) | 11% | 6.1% | 8.1% | 6.2% | 6.6% | 17% | 6.0% |
Treatment Success Rate (2022) | 74% | 86% | 88% | 86% | 86% | 74% | 84% |
Resources
Support for CDC's global HIV and TB efforts.
Our success is built on the backbone of science and partnerships.